Kentaro Hanami

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

Yoshiya Tanaka, Shintaro Hirata, Satoshi Kubo et al. · Annals of the Rheumatic Diseases · 2013 · 187 citations · Full text

Dopamine Induces IL-6–Dependent IL-17 Production via D1-Like Receptor on CD4 Naive T Cells and D1-Like Receptor Antagonist SCH-23390 Inhibits Cartilage Destruction in a Human Rheumatoid Arthritis/SCID Mouse Chimera Model

Kazuhisa Nakano, Kunihiro Yamaoka, Kentaro Hanami et al. · The Journal of Immunology · 2011 · 124 citations · Full text

Adaptive Immune System, Immunology, Immune Regulation +23

Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients

Satoshi Kubo, Shingo Nakayamada, Maiko Yoshikawa et al. · Arthritis & Rheumatology · 2017 · 99 citations

Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study

Tsutomu Takeuchi, Yoshiya Tanaka, Koichi Amano et al. · Lara D. Veeken · 2011 · 89 citations · Full text

Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study)

Hisashi Yamanaka, Yoshiya Tanaka, Eisuke Inoue et al. · Modern Rheumatology · 2010 · 83 citations · Full text

Inflammation, Rheumatology, Daily Clinical Practice +15